RP
LLY icon

Riverwater Partners’s Eli Lilly LLY Stock Holding History

Riverwater Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
1,255
+98
+8% +$100K 0.45% 79
2026
Q1 		$1.06M Sell
1,157
-239
-17% -$242K 0.35% 88
2025
Q4 		$1.5M Buy
1,396
+26
+2% +$24.9K 0.58% 62
2025
Q3 		$1.05M Buy
1,370
+136
+11% +$101K 0.43% 70
2025
Q2 		$962K Buy
1,234
+33
+3% +$25.6K 0.45% 73
2025
Q1 		$992K Buy
1,201
+133
+12% +$111K 0.51% 66
2024
Q4 		$824K Buy
1,068
+6
+0.6% +$4.97K 0.4% 70
2024
Q3 		$946K Sell
1,062
-27
-2% -$24.3K 0.47% 66
2024
Q2 		$986K Buy
1,089
+94
+9% +$75.2K 0.73% 33
2024
Q1 		$774K Buy
+995
New +$708K 0.57% 43
2022
Q4 		– Sell
-2,084
Closed -$674K – 210
2022
Q3 		$674K Buy
+2,084
New +$660K 0.67% 42

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Riverwater Partners's LLY Position: Q2 2026 in Review

Riverwater Partners increased its Eli Lilly (LLY) stake by 8.5% in Q2 2026, buying an estimated $100K and bringing the position to 1,255 shares worth $1.51M. The position accounts for 0.45% of the portfolio, ranked #79.

Riverwater Partners first reported a position in LLY in Q3 2022 and has held it in 11 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Riverwater Partners held 1,255 shares of Eli Lilly worth $1.51M as of Q2 2026.
  • Riverwater Partners bought 98 Eli Lilly shares in Q2 2026, an estimated $100K.
  • Eli Lilly made up 0.45% of Riverwater Partners's portfolio in Q2 2026, its #79 holding.
  • Riverwater Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 11 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.